Multimodal treatment of perianal fistulas in Crohns Disease: seton versus anti-TNF versus advancement plasty
Phase of Trial: Phase IV
Latest Information Update: 05 Mar 2019
Price : $35 *
At a glance
- Drugs Adalimumab (Primary) ; Infliximab (Primary) ; Tumour necrosis factor alpha inhibitors
- Indications Crohn's disease
- Focus Therapeutic Use
- Acronyms PISA
- 03 Mar 2019 Status changed from recruiting to discontinued.
- 14 Sep 2013 New source identified and integrated (European Clinical Trials Database: EudraCT2013-002932-25).
- 04 Sep 2013 New trial record